Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway

• Published in: Stem cell research & therapy 2019-04, Vol.10 (1), p.117-117, Article 117
• Main Authors: Wang, Shihua, Su, Xiaodong, Xu, Meiqian, Xiao, Xian, Li, Xiaoxia, Li, Hongling, Keating, Armand, Zhao, Robert Chunhua
• Format: Article
• Language: English
• Subjects: Adipocyte; Adipocytes; Angiogenesis; Apoptosis; Breast cancer; Cancer cells; Cell activation; Cell growth; Cell interactions; Cell proliferation; Cell signaling; Cellular signal transduction; Chemotherapy; Development and progression; Exosomes; Fibroblasts; Fluorescent antibody technique; Health aspects; Hippo signaling pathway; Immunofluorescence; Leukocyte migration; Macrophages; Mesenchymal stromal/stem cell; Mesenchyme; Microscopy; Novels; Physiological aspects; Signal transduction; Stem cells; Tumors; Wound care; Wound healing; Xenografts
• ISSN: 1757-6512; 1757-6512
• DOI: 10.1186/s13287-019-1220-2

Although adipocytes are the most abundant stromal cell component in breast cancer tissues, their interaction with breast cancer cells has been less investigated compared to cancer-associated fibroblasts or macrophages. Exosomes are a novel way of cell-cell communication and have been demonstrated to play an important role in various biological processes. However, to our knowledge, only a few studies have reported the effects of adipocyte exosomes on tumor development. Here, utilizing exosomes isolated from in vitro mesenchymal stromal/stem cell (MSC)-differentiated adipocytes, we systematically investigated this issue in a breast cancer model. Exosomes were isolated from MSC-differentiated adipocytes and added to breast cancer cells MCF7. Cell proliferation was detected by MTS, and migration was analyzed by wound healing and transwell assay. An in vivo mouse xenograft model was used to evaluate MSC-differentiated adipocyte exosomes' contribution to tumor growth. Signaling pathway activation was evaluated by western blot and immunofluorescence staining. We found MSC-differentiated adipocyte-derived exosomes are actively incorporated by breast cancer cell MCF7 and subsequently promote MCF7 proliferation and migration as well as protect MCF7 from serum derivation or chemotherapeutic drug-induced apoptosis in vitro. In the in vivo mouse xenograft model, depletion of exosomes reduces tumor-promoting effects of adipocytes. Transcriptomic analysis of MSC-differentiated adipocyte exosome-treated MCF7 identified several activated signaling pathways, among which we confirm the Hippo signaling pathway and found a blockade of this pathway leads to a reduced growth-promoting effect of adipocyte exosomes. Taken together, our findings provide new insights into the role of adipocyte exosomes in the tumor microenvironment.